|
1
|
Miller AJ and Mihm MC Jr: Melanoma. N Engl
J Med. 355:51–65. 2006. View Article : Google Scholar
|
|
2
|
Trinh VA: Current management of metastatic
melanoma. Am J Health Syst Pharm. 65:S3–S8. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geller AC, Swetter SM, Brooks K, Demierre
MF and Yaroch AL: Screening, early detection, and trends for
melanoma: current status (2000–2006) and future directions. J Am
Acad Dermatol. 57:555–576. 2007.PubMed/NCBI
|
|
4
|
Geller AC, Swetter SM, Oliveria S, Dusza S
and Halpern AC: Reducing mortality in individuals at high risk for
advanced melanoma through education and screening. J Am Acad
Dermatol. 65:S87–S94. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Turner RM, Bell KJ, Morton RL, et al:
Optimizing the frequency of follow-up visits for patients treated
for localized primary cutaneous melanoma. J Clin Oncol.
29:4641–4646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gubbay J, Collignon J, Koopman P, et al: A
gene mapping to the sex-determining region of the mouse Y
chromosome is a member of a novel family of embryonically expressed
genes. Nature. 346:245–250. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wegner M: From head to toes: the multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burtscher I, Barkey W, Schwarzfischer M,
Theis FJ and Lickert H: The Sox17-mCherry fusion mouse line allows
visualization of endoderm and vascular endothelial development.
Genesis. 50:496–505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niakan KK, Ji H, Maehr R, et al: Sox17
promotes differentiation in mouse embryonic stem cells by directly
regulating extraembryonic gene expression and indirectly
antagonizing self-renewal. Genes Dev. 24:312–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen HL, Chew LJ, Packer RJ and Gallo V:
Modulation of the Wnt/beta-catenin pathway in human
oligodendroglioma cells by Sox17 regulates proliferation and
differentiation. Cancer Lett. 335:361–371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jia Y, Yang Y, Liu S, Herman JG, Lu F and
Guo M: SOX17 antagonizes WNT/β-catenin signaling pathway in
hepatocellular carcinoma. Epigenetics. 5:743–749. 2010.
|
|
12
|
Ye YW, Wu JH, Wang CM, et al: Sox17
regulates proliferation and cell cycle during gastric cancer
progression. Cancer Lett. 307:124–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li D, Beisswenger C, Herr C, et al:
Myeloid cell RelA/p65 promotes lung cancer proliferation through
Wnt/β-catenin signaling in murine and human tumor cells. Oncogene.
33:1239–1248. 2013.PubMed/NCBI
|
|
14
|
Yang L, Chen Y, Cui T, et al: Desmoplakin
acts as a tumor suppressor by inhibition of the Wnt/β-catenin
signaling pathway in human lung cancer. Carcinogenesis.
33:1863–1870. 2012.PubMed/NCBI
|
|
15
|
Zeitlin BD, Ellis LM and Nor JE:
Inhibition of vascular endothelial growth factor
receptor-1/Wnt/{beta}-catenin crosstalk leads to tumor cell death.
Clin Cancer Res. 15:7453–7455. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fodde R and Brabletz T: Wnt/β-catenin
signaling in cancer stemness and malignant behavior. Curr Opin Cell
Biol. 19:150–158. 2007.
|
|
17
|
Fu DY, Wang ZM, Li C, et al: Sox17, the
canonical Wnt antagonist, is epigenetically inactivated by promoter
methylation in human breast cancer. Breast Cancer Res Treat.
119:601–612. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W, Glockner SC, Guo M, et al:
Epigenetic inactivation of the canonical Wnt antagonist SRY-box
containing gene 17 in colorectal cancer. Cancer Res. 68:2764–2772.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du YC, Oshima H, Oguma K, et al: Induction
and down-regulation of Sox17 and its possible roles during the
course of gastrointestinal tumorigenesis. Gastroenterology.
137:1346–1357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chu IM, Hengst L and Slingerland JM: The
Cdk inhibitor p27 in human cancer: prognostic potential and
relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wander SA, Zhao D and Slingerland JM: p27:
a barometer of signaling deregulation and potential predictor of
response to targeted therapies. Clin Cancer Res. 17:12–18. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen G, Cheng Y, Zhang Z, Martinka M and
Li G: Prognostic significance of cytoplasmic p27 expression in
human melanoma. Cancer Epidemiol Biomarkers Prev. 20:2212–2221.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tao GZ, Lehwald N, Jang KY, et al:
Wnt/β-catenin signaling protects mouse liver against oxidative
stress-induced apoptosis through the inhibition of forkhead
transcription factor FoxO3. J Biol Chem. 288:17214–17224. 2013.
|
|
24
|
Dai DL, Martinka M and Li G: Prognostic
significance of activated Akt expression in melanoma: a
clinicopathologic study of 292 cases. J Clin Oncol. 23:1473–1482.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin H, Wong RP, Martinka M and Li G: Loss
of SNF5 expression correlates with poor patient survival in
melanoma. Clin Cancer Res. 15:6404–6411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang H, Lee S, Kim K, et al: Sox17
promotes tumor angiogenesis and destabilizes tumor vessels in mice.
J Clin Invest. 123:418–431. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin D, Jia Y, Yu Y, et al: SOX17
methylation inhibits its antagonism of Wnt signaling pathway in
lung cancer. Discov Med. 14:33–40. 2012.PubMed/NCBI
|
|
28
|
Jia Y, Yang Y, Zhan Q, et al: Inhibition
of SOX17 by microRNA 141 and methylation activates the WNT
signaling pathway in esophageal cancer. J Mol Diagn. 14:577–585.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oishi Y, Watanabe Y, Yoshida Y, et al:
Hypermethylation of Sox17 gene is useful as a molecular diagnostic
application in early gastric cancer. Tumour Biol. 33:383–393. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tarhini AA and Agarwala SS: Cutaneous
melanoma: available therapy for metastatic disease. Dermatol Ther.
19:19–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sinner D, Kordich JJ, Spence JR, et al:
Sox17 and Sox4 differentially regulate β-catenin/T-cell factor
activity and proliferation of colon carcinoma cells. Mol Cell Biol.
27:7802–7815. 2007.PubMed/NCBI
|
|
32
|
Sohn J, Natale J, Chew LJ, et al:
Identification of Sox17 as a transcription factor that regulates
oligodendrocyte development. J Neurosci. 26:9722–9735. 2006.
View Article : Google Scholar : PubMed/NCBI
|
